AU6032100A - New compounds - Google Patents

New compounds

Info

Publication number
AU6032100A
AU6032100A AU60321/00A AU6032100A AU6032100A AU 6032100 A AU6032100 A AU 6032100A AU 60321/00 A AU60321/00 A AU 60321/00A AU 6032100 A AU6032100 A AU 6032100A AU 6032100 A AU6032100 A AU 6032100A
Authority
AU
Australia
Prior art keywords
new compounds
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60321/00A
Inventor
Yevgeni Besidski
Britt-Marie Swahn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU6032100A publication Critical patent/AU6032100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
AU60321/00A 1999-06-16 2000-06-15 New compounds Abandoned AU6032100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9902267 1999-06-16
SE9902267A SE9902267D0 (en) 1999-06-16 1999-06-16 New compounds
PCT/SE2000/001250 WO2000076990A1 (en) 1999-06-16 2000-06-15 New compounds

Publications (1)

Publication Number Publication Date
AU6032100A true AU6032100A (en) 2001-01-02

Family

ID=20416099

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60321/00A Abandoned AU6032100A (en) 1999-06-16 2000-06-15 New compounds

Country Status (3)

Country Link
AU (1) AU6032100A (en)
SE (1) SE9902267D0 (en)
WO (1) WO2000076990A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5319700A (en) * 1999-06-02 2000-12-18 S. Mbua Ngale Efange Nicotine receptor ligands
WO2003020728A1 (en) 2001-08-30 2003-03-13 Pharmacia & Upjohn Company 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
WO2003029238A1 (en) 2001-10-04 2003-04-10 Wyeth Chroman derivatives as 5-hydroxytryptamine-6 ligands
WO2003029239A1 (en) 2001-10-04 2003-04-10 Wyeth Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands
AR038294A1 (en) 2002-01-14 2005-01-12 Upjohn Co OXOTIENE (3,2-B) PYRIDINCARBOXAMIDS AS ANTIVIRAL AGENTS
AR038117A1 (en) 2002-01-14 2004-12-29 Upjohn Co ANTIVIRAL AGENTS DERIVED FROM 4- OXO-4,7 -DIHYDROFIDE [2,3-B] PIRIDIN-5-CARBOXAMIDA
AR038118A1 (en) 2002-01-14 2004-12-29 Upjohn Co COMPOUNDS DERIVED FROM ACID BENCINAMIDE 7-OXO-4,7-DIHIDROTIEN [2,3-B [PIRIDIN-6-CARBOXYLIC 3-REPLACED WHICH ARE USEFUL AS ANTIVIRAL
US7728155B2 (en) 2003-10-24 2010-06-01 Wyeth Llc Dihydrobenzofuranyl alkanamines and methods for using same as cns agents
AR056979A1 (en) * 2005-04-22 2007-11-07 Wyeth Corp DERIVATIVES OF DIHYDROBENZOFURANS AND USES OF THE SAME
MX2007013024A (en) * 2005-04-22 2009-02-16 Wyeth Corp Treatment of drug abuse.
CN101189004A (en) * 2005-04-22 2008-05-28 惠氏公司 Treatment of pain
EP1871355A1 (en) 2005-04-22 2008-01-02 Wyeth New therapeutic combianations for the treatment or prevention of depression
MY188160A (en) * 2015-02-11 2021-11-24 Sunovion Pharmaceuticals Inc 1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders
CA3127789A1 (en) 2019-02-01 2020-08-06 Fmc Corporation Diamino-substituted pyridines and pyrimidines as herbicides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3513239A (en) * 1967-03-15 1970-05-19 Smithkline Corp Pharmaceutical compositions containing 2-aminoalkyl coumaran derivatives and methods of treating depression therewith
CH567011A5 (en) * 1972-12-19 1975-09-30 Eisai Co Ltd
NZ201219A (en) * 1981-07-28 1984-10-19 Reckitt & Colmann Prod Ltd Dihydrobenzofuranyl-2-imidazolines and pharmaceutical compositions
JPH077508B2 (en) * 1988-11-16 1995-01-30 株式会社東芝 Magnetic disk manufacturing method
GB9020128D0 (en) * 1990-09-14 1990-10-24 Reckitt & Colmann Prod Ltd Imidazoline derivatives
IE68675B1 (en) * 1990-11-01 1996-07-10 Takeda Chemical Industries Ltd Aminocoumaran derivatives their production and use
FR2761072B1 (en) * 1997-03-20 1999-04-23 Synthelabo 2,3-DIHYDROFURO [3,2-B] PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
SE9902267D0 (en) 1999-06-16
WO2000076990A1 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
AU5413600A (en) Compounds
AU1278701A (en) Novel compounds
AUPP999799A0 (en) New compound
AU2408300A (en) Novel compounds
AU6032100A (en) New compounds
AU1746401A (en) Compounds
AUPQ441499A0 (en) Novel compound
AU3997700A (en) Anti-first-pass effect compounds
AU2023701A (en) Sketcher
AU4132200A (en) Novel compounds
AU5887400A (en) Derivative compounds
AU2109700A (en) Novel compounds
AU5787901A (en) Compound
AU1901801A (en) Glucofuranoses
AU6567400A (en) Substituted 2-imino-thiazolines
AU1915601A (en) Periotome
AU5119400A (en) Compounds
AU2288900A (en) Novel compounds
AU2197301A (en) Microlamp
AU6168900A (en) Compounds
AU2668000A (en) Bis-styrylbiphenyl compounds
AU4156800A (en) Novel compounds
AU7784700A (en) Novel compounds
AU1385701A (en) Novel compounds
AU6831100A (en) Substituted heterocyclybenzofuranes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase